ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | Effects of canagliflozin versus finerenone on cardiorenal outcomes

Effects of canagliflozin versus finerenone on cardiorenal outcomes

Share

https://www.youtube.com/watch?v=eOD4qajQ8EI copy

Other e-seminars from this series

Social determinants of health and the transition from advanced chronic kidney disease to kidney failure

Renal artery stenting in the correct patients with atherosclerotic renovascular disease

Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching study

Intravenous sodium thiosulphate treatment for vascular calcification of hemodialysis patients

A prediction model improves the predictive ability for renal replacement therapy

Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring

Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis

Renal events in patients receiving Neprilysin inhibitors: a systematic review and meta-analysis